Finally, we reported a case that illustrated the application of cdPCR in detecting low-allele burdens in a de novo chronic myeloid leukemia (CML) patient with a hidden JAK2 V617F subclone, which expanded during TKI treatment. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.